Oncology APIs & Intermediates
Precision at the Molecular Level - Redefining Oncology Manufacturing
At Sarv Biolabs, we believe that life-saving drugs are developed at the bench and built from the molecular level up long before they are administered to the patient. Sarv Biolabs is an established manufacturer of oncology active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, the foundation upon which cancer treatment throughout the world is administered.
Our facility is constructed on principles of science, infrastructure, and an unfailing commitment to quality. We collaborate with pharmaceutical companies, formulators, and exporters looking for reliable manufacturing expertise. When there is no compromise in quality, they partner with Sarv Biolabs.
From Molecules to Medicine - Our Product Spectrum
We, Sarv Biolabs, manufacture oncology APIs and pharmaceutical intermediates, which include Etoposide and Dasatinib for worldwide pharmaceutical manufacturers
Etoposide
- Etoposide is a well-known oncology API and is a prescribed treatment for multiple cancers. This includes testicular cancer and lung cancer. This compound inhibits one of the enzymes that the cancer cell utilizes in order to reproduce.
- Etoposide is commercially synthesized by Sarv Biolabs under pharmaceutical-grade specifications. As a result, formulators and pharmaceutical manufacturers around the world can be confident in their products’ consistency
Dasatinib
- Dasatinib is a precision oncology API for the treatment of chronic myeloid and acute lymphoblastic leukemia primarily. It inhibits two types of proteins that send the signal for tumor reproduction to cancer cells. Furthermore, it functions as an oncology API, prohibiting these proteins.
- Sarv Biolabs synthesizes and produces this compound under stringent quality processes to cater to the pharma companies requiring dependable and pure active ingredients.
- With an increasing product list, we will strive to continue enabling access to affordable and effective treatment for cancer worldwide.
A Wide Range of Oncology APIs & Intermediates by Sarv Biolabs
Sarv Biolabs is engaged in offering a wide spectrum of Oncology APIs and intermediates. Which are divided into Finished API and Synthesis intermediate.
The Finished APIs
- Paclitaxel IP/USP/EP
- Docetaxel Trihydrate IP/USP/EP
- Docetaxel Anhydrous IP/USP/EP
- Lenalidomide Base & HCL
- Etoposide
- Dasatinib
Synthesis intermediate
- 10-De acetyl Baccatin III
- 7-TROC Paclitaxel
- 7,10 Di TROC Docetaxel
The Sarv Biolabs Advantage: Precision, Purity, and Partnership
Selecting an oncology manufacturing partner can be an area where patients’ lives depend on the decisions made. The combination of technical skill, certified facility, and dedication to quality is found at Sarv Biolabs, a partner, not just a supplier.
We adhere to the pharmaceutical industry’s specific quality requirements and regulations; our goals extend beyond order fulfillment; and we strive to establish a mutually beneficial long-term relationship.
We partner with those who see quality as important as we do; choose Sarv Biolabs if your business requirements include quality, on-time, oncology API, and intermediate manufacturing. We can build something better together.